Identification of Factors Influencing the Intervention Thresholds for Treatment of Osteoporosis Based on 10-Year Absolute Fracture Risks

Journal of Clinical Densitometry

Volumn 12, Issue 1, 2009, Pages 1-4

  Moayyeri, Alireza ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ALGORITHM; BONE DENSITY; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; EDITORIAL; FEMALE; FEMUR NECK; FRAGILITY FRACTURE; HUMAN; LIFE EXPECTANCY; MATHEMATICAL MODEL; OSTEOPOROSIS; PATIENT CARE; POSTMENOPAUSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; WORLD HEALTH ORGANIZATION;

ALGORITHMS; FRACTURES, BONE; HUMANS; OSTEOPOROSIS; QUALITY-ADJUSTED LIFE YEARS; RISK ASSESSMENT; RISK FACTORS;

EID: 59049090300     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocd.2008.10.001     Document Type: Editorial

References (33)

1. Kanis J.A., Johnell O., Oden A., et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12 (2001) 989-995
2. Kanis J.A., Borgstrom F., De Laet C., et al. Assessment of fracture risk. Osteoporos Int 16 (2005) 581-589
3. Siminoski K., Leslie W.D., Frame H., et al. Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J 56 (2005) 178-188
4. Tucker G., Metcalfe A., Pearce C., et al. The importance of calculating absolute rather than relative fracture risk. Bone 41 (2007) 937-941
5. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843 (1994) 1-129
6. Brown J.P., and Josse R.G. 2002 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167 (2002) S1-S34
7. Kanis J.A., and Gluer C.C. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int 11 (2000) 192-202
8. Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Executive summary. Osteoporos Int 8 Suppl 4 (1998) S3-S6
9. Hodgson S.F., Watts N.B., Bilezikian J.P., et al. American Association of Clinical Endocrinologists 2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis. Endocr Pract 7 (2001) 293-312
10. Osteoporosis prevention, diagnosis, and therapy. JAMA 285 (2001) 785-795
11. De Laet C., Oden A., Johansson H., et al. The impact of the use of multiple risk indicators for fracture on case-finding strategies: a mathematical approach. Osteoporos Int 16 (2005) 313-318
12. Melton III L.J. The prevalence of osteoporosis: gender and racial comparison. Calcif Tissue Int 69 (2001) 179-181
13. Cummings S.R., Bates D., and Black D.M. Clinical use of bone densitometry: scientific review. JAMA 288 (2002) 1889-1897
14. Leslie W.D., Metge C., and Ward L. Contribution of clinical risk factors to bone density-based absolute fracture risk assessment in postmenopausal women. Osteoporos Int 14 (2003) 334-338
15. Melton III L.J., Johnell O., Lau E., et al. Osteoporosis and the global competition for health care resources. J Bone Miner Res 19 (2004) 1055-1058
16. Leslie W.D., Siminoski K., and Brown J.P. Comparative effects of densitometric and absolute fracture risk classification systems on projected intervention rates in postmenopausal women. J Clin Densitom 10 (2007) 124-131
17. Marshall D., Johnell O., and Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312 (1996) 1254-1259
18. Kanis J.A., Johnell O., De Laet C., et al. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res 17 (2002) 1237-1244
19. Nguyen N.D., Ahlborg H.G., Center J.R., et al. Residual lifetime risk of fractures in women and men. J Bone Miner Res 22 (2007) 781-788
20. Abrahamsen B., Vestergaard P., Rud B., et al. Ten-year absolute risk of osteoporotic fractures according to BMD T score at menopause: the Danish Osteoporosis Prevention Study. J Bone Miner Res 21 (2006) 796-800
21. Nguyen N.D., Frost S.A., Center J.R., et al. Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int 18 (2007) 1109-1117
22. Kanis JA. On behalf of the World Health Organization Scientific Group. Assessment of osteoporosis at the primary health-care level. Technical Report. University of Sheffield, UK, World Health Organization Collaborating Center for Metabolic Bone Disease, 2007.
23. Kanis J.A., Johnell O., Oden A., et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19 (2008) 385-397
24. Kanis J.A., McCloskey E.V., Johansson H., et al. Case finding for the management of osteoporosis with FRAX((R))-assessment and intervention thresholds for the UK. Osteoporos Int 19 (2008) 1395-1408
25. Kannel W.B., McGee D., and Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 38 (1976) 46-51
26. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
27. Schwartz A.V., Kelsey J.L., Maggi S., et al. International variation in the incidence of hip fractures: cross-national project on osteoporosis for the World Health Organization Program for Research on Aging. Osteoporos Int 9 (1999) 242-253
28. Johnell O., Kanis J.A., Oden A., et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res 20 (2005) 1185-1194
29. Drummond M.F., Sculpher M.J., Torrance G.W., et al. Methods for the Economic Evaluation of Health Care Programmes (2005), Oxford University Press, Oxford
30. National Institute for Health and Clinical Excellence. Final Appraisal Determination: Alendronate, Etidronate, Risedronate, Raloxifene and Strontium Ranelate for the Primary Prevention of Osteoporotic Fragility Fractures in Postmenopausal Women (2007), NICE, London
31. Kanis J.A., Adams J., Borgstrom F., et al. The cost-effectiveness of alendronate in the management of osteoporosis. Bone 42 (2008) 4-15
32. Kanis J.A., Burlet N., Cooper C., et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008)
33. Kanis J.A., Oden A., Johnell O., et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18 (2007) 1033-1046